Rosie Mngqibisa
Durban, ZN, South Africa
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Editorial: Transitioning through menopause: contraceptive choices and sexual well-being.
Journal: Frontiers in reproductive health
Published: June 23, 2026
Efficacy and safety of short-cycle, dolutegravir-based antiretroviral therapy in adolescents living with HIV (BREATHER Plus): a multicentre, open-label, randomised, parallel, two-arm, non-inferiority trial.
Journal: The lancet. HIV
Published: September 03, 2025
Switch to fixed-dose doravirine (100 mg) and islatravir (0·25 mg) once daily in virologically suppressed adults with HIV-1 on oral antiretroviral therapy: 48-week results of a phase 3, multicentre, randomised, open-label, non-inferiority trial.
Journal: Lancet (London, England)
Published: August 04, 2025
Early versus deferred antiretroviral therapy initiation and long-term cardiovascular disease outcomes in people with HIV: The START study.
Journal: Open forum infectious diseases
Published: April 18, 2025
A Phase 3 Study of the Safety and Efficacy of Tedizolid Phosphate in Patients <12 Years of Age With Acute Bacterial Skin and Skin Structure Infections.
Journal: The Pediatric infectious disease journal
Published: April 15, 2025
Efficacy and safety of doravirine/islatravir in heavily treatment-experienced participants living with HIV-1: results from a randomized trial.
Journal: AIDS (London, England)
Published: April 10, 2025
Correction: Extensive cervical lesion and treatment outcomes in women with HIV/HPV co-infection.
Journal: AIDS research and therapy
Published: March 24, 2025
The 96-week outcomes and pharmacokinetics of long-acting cabotegravir plus rilpivirine in South Africans.
Journal: Southern African journal of HIV medicine
Published: February 05, 2025
Virological and drug-resistance outcomes for people living with HIV initiating or switching to tenofovir, lamivudine, and dolutegravir in six PEPFAR-supported countries: a prospective cohort study.
Journal: The lancet. HIV
Published: January 18, 2025
Immunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-MTM adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trial.
Journal: Human vaccines & immunotherapeutics
Published: December 12, 2024
Extensive cervical lesion and treatment outcomes in women with HIV/HPV co-infection.
Journal: AIDS research and therapy
Published: October 17, 2024
Mortality and Associated Risk Factors Among People Living With HIV With Kaposi Sarcoma: A5263/AMC066 and A5264/AMC067.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: January 19, 2024
Last Updated: 09/26/2026